Works by Fernandes, Gustavo A. B.

Results: 5

The Novel H4R Antagonist 1-[(5-Chloro-2,3-Dihydro-1-Benzofuran-2-Yl)Methyl]-4-Methyl-Piperazine (LINS01007) Attenuates Several Symptoms in Murine Allergic Asthma.
Published in:
Cellular Physiology & Biochemistry (Cell Physiol Biochem Press GmbH & Co. KG), 2021, v. 55, n. 6, p. 1163, doi. 10.33594/000000307
By:
- Balbino, Aleksandro M.;
- Lima, Leandro J. S.;
- Fernandes, Gustavo A. B.;
- Corrêa, Michele F.;
- Gomes, Eliane;
- Landgraf, Maristella A.;
- Fernandes, João Paulo S.;
- Landgraf, Richardt G.
Publication type:
Article
The Novel H4R Antagonist 1-[(5-Chloro- 2,3-Dihydro-1-Benzofuran-2-Yl)Methyl]-4- Methyl-Piperazine (LINS01007) Attenuates Several Symptoms in Murine Allergic Asthma.
Published in:
Cellular Physiology & Biochemistry (Cell Physiol Biochem Press GmbH & Co. KG), 2020, v. 54, n. 6, p. 1163, doi. 10.33594/000000307
By:
- Balbino, Aleksandro M.;
- Lima, Leandro J. S.;
- Fernandes, Gustavo A. B.;
- Corrêa, Michele F.;
- Gomes, Eliane;
- Landgraf, Maristella A.;
- Fernandes, João Paulo S.;
- Landgraf, Richardt G.
Publication type:
Article
Evaluation of the histamine H3 receptor antagonists from LINS01 series as cholinesterases inhibitors: Enzymatic and modeling studies.
Published in:
Chemical Biology & Drug Design, 2022, v. 100, n. 5, p. 722, doi. 10.1111/cbdd.14139
By:
- Lopes, Flávia B.;
- Aranha, Cecília M. S. Q.;
- Corrêa, Michelle F.;
- Fernandes, Gustavo A. B.;
- Okamoto, Debora N.;
- Simões, Leonardo P. M.;
- Junior, Nailton M. N.;
- Fernandes, João Paulo S.
Publication type:
Article
Profiling of LINS01 compounds at human dopamine D2 and D3 receptors.
Published in:
Journal of Chemical Sciences, 2020, v. 132, n. 1, p. 1, doi. 10.1007/s12039-019-1694-6
By:
- Corrêa, Michelle F;
- Reiner, David;
- Fernandes, Gustavo A B;
- Varela, Marina T;
- Aranha, Cecília M S Q;
- Stark, Holger;
- Fernandes, João Paulo S
Publication type:
Article
Decreased Neurofilament L Chain Levels in Cerebrospinal Fluid and Tolerogenic Plasmacytoid Dendritic Cells in Natalizumab-Treated Multiple Sclerosis Patients – Brief Research Report.
Published in:
Frontiers in Cellular Neuroscience, 2021, v. 15, p. 1, doi. 10.3389/fncel.2021.705618
By:
- Moraes, Adriel S.;
- Boldrini, Vinicius O.;
- Dionete, Alliny C.;
- Andrade, Marilia D.;
- Longhini, Ana Leda F.;
- Santos, Irene;
- Lima, Amanda D. R.;
- Silva, Veronica A. P. G.;
- Dias Carneiro, Rafael P. C.;
- Quintiliano, Raphael P. S.;
- Ferrari, Breno B.;
- Damasceno, Alfredo;
- Pradella, Fernando;
- Farias, Alessandro S.;
- Tilbery, Charles P.;
- Domingues, Renan B.;
- Senne, Carlos;
- Fernandes, Gustavo B. P.;
- von Glehn, Felipe;
- Brandão, Carlos Otavio
Publication type:
Article

Works by Fernandes, Gustavo A. B.

The Novel H<sub>4</sub>R Antagonist 1-[(5-Chloro-2,3-Dihydro-1-Benzofuran-2-Yl)Methyl]-4-Methyl-Piperazine (LINS01007) Attenuates Several Symptoms in Murine Allergic Asthma.

The Novel H<sub>4</sub>R Antagonist 1-[(5-Chloro- 2,3-Dihydro-1-Benzofuran-2-Yl)Methyl]-4- Methyl-Piperazine (LINS01007) Attenuates Several Symptoms in Murine Allergic Asthma.

Evaluation of the histamine H<sub>3</sub> receptor antagonists from LINS01 series as cholinesterases inhibitors: Enzymatic and modeling studies.

Profiling of LINS01 compounds at human dopamine D2 and D3 receptors.

Decreased Neurofilament L Chain Levels in Cerebrospinal Fluid and Tolerogenic Plasmacytoid Dendritic Cells in Natalizumab-Treated Multiple Sclerosis Patients – Brief Research Report.